Key result
A review of pharmacological and psychological treatments for self-harm contrasts evidence from randomized controlled trials with observational data, highlighting challenges in trial design.
Why the study?
Do pharmacological and psychological treatments prevent self-harm repetition in individuals who self-harm?
Do pharmacological and psychological treatments prevent self-harm repetition in individuals who self-harm?
This review summarizes the current evidence from RCTs and observational studies on the effectiveness of pharmacological and psychological interventions in preventing self-harm.
Answers are grounded in this paper and cite their sources.
Evidence too limited for treatment recommendations in self-harm; leaves open questions on optimal RCT designs.
Self-harm is a major public health concern and a risk factor for future suicide. It predominantly occurs in young people with around 65% of self-harm occurring before the age of 35. Self-harm causes distress to families and is associated with poorer educational outcomes as well as increased health and social care costs. Repetition is common with a quarter of individuals presenting to hospital with a further episode of self-harm within a year. We review the evidence from randomised controlled trials of treatments for self-harm, focusing on pharmacological and psychological approaches. We then contrast this with the current observational evidence and reflect on the challenges and limitations of randomised controlled trials for the treatment of self-harm.
No takes yet. Share an insight, caveat, or question.
Saunders et al. (2016) conducted a review in Self-harm. Pharmacological and psychological approaches was evaluated. A review of pharmacological and psychological treatments for self-harm contrasts evidence from randomized controlled trials with observational data, highlighting challenges in trial design.
Synapse has enriched 10 related papers. Consider them for comparative context: